PP
CVS icon

PagnatoKarp Partners’s CVS Health CVS Stock Holding History

PagnatoKarp Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,310
Closed -$671K – 33
2020
Q1 		$671K Buy
11,310
+305
+3% +$20.4K 0.17% 74
2019
Q4 		$818K Buy
11,005
+23
+0.2% +$1.61K 0.14% 74
2019
Q3 		$693K Buy
10,982
+4,235
+63% +$251K 0.14% 82
2019
Q2 		$368K Buy
6,747
+1,293
+24% +$69.6K 0.08% 131
2019
Q1 		$294K Buy
+5,454
New +$337K 0.07% 136

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

PagnatoKarp Partners's CVS Position: Q2 2020 in Review

PagnatoKarp Partners sold out of CVS Health (CVS) in Q2 2020, closing a stake of 11,310 shares — an estimated $671K sold.

PagnatoKarp Partners first reported a position in CVS in Q1 2019 and held it in 5 quarters. The position peaked at $818K in Q4 2019. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • PagnatoKarp Partners reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • PagnatoKarp Partners sold 11,310 CVS Health shares in Q2 2020, an estimated $671K.
  • PagnatoKarp Partners first reported a position in CVS Health in Q1 2019 and held it in 5 quarters.
  • PagnatoKarp Partners's CVS Health position peaked at $818K in Q4 2019.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on PagnatoKarp Partners's 13F filing for Q2 2020.